RedHill Biopharma Income Statement (2011-2025) | RDHL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.00B	0.00B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.02B	0.02B	0.01B	0.00B	0.00B
Gross Profit (Quarter)	0.00B	-0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B
Operating items
Research & Development (Quarter)	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Operating Expenses (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Operating Income (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	-0.14B	0.02B	0.01B	0.01B	-0.08B	-0.03B	0.05B
EBIT (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	-0.14B	0.02B	0.01B	0.01B	-0.08B	-0.03B	0.05B
Non-operating items
Interest & Investment Income (Quarter)	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.02B	0.01B
Other Non Operating Income (Quarter)	-0.00B
Non Operating Income (Quarter)	-0.00B		0.00B	0.00B	0.00B	0.00B		0.00B	-0.03B	0.00B	-0.01B	0.03B	-0.06B	-0.02B	0.05B
Net income details
EBT (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.01B	0.02B	0.01B	-0.15B	0.01B	0.01B	-0.02B	-0.07B	-0.01B	0.06B
Profit After Tax (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	0.03B	-0.02B	-0.02B	0.02B	0.01B	-0.04B	-0.00B	-0.05B	0.10B
Income from Continuing Operations (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.01B	0.02B	0.01B	-0.15B	0.01B	0.01B	-0.02B	-0.07B	-0.01B	0.06B
Consolidated Net Income (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.01B	0.02B	0.01B	-0.15B	0.01B	0.01B	-0.02B	-0.07B	-0.01B	0.06B
Income towards Parent Company (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.01B	0.02B	0.01B	-0.15B	0.01B	0.01B	-0.02B	-0.07B	-0.01B	0.06B
Net Income towards Common Stockholders (Quarter)	0.01B	0.02B	0.01B	0.01B	0.02B	0.01B	0.02B	0.01B	-0.15B	0.01B	0.01B	-0.02B	-0.07B	-0.01B	0.06B
Additional items
EPS (Basic) (Quarter)	0.03	0.05	0.04	0.05	0.07	0.05	0.06	0.05	-0.37	0.04	0.02	0.06	-0.24	-0.05	0.09
EPS (Weighted Average and Diluted) (Quarter)							0.06				0.02
Shares Outstanding (Weighted Average) (Quarter)	0.30B	0.00B	0.00B	0.00B	0.36B	0.00B	0.00B	0.00B	0.47B	0.00B	0.00B	0.00B	0.62B	0.00B	0.00B	2.59B	0.03B	0.04B	0.06B	0.15B
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.02B	-0.14B	0.02B	0.01B	0.04B	-0.08B	-0.03B	0.05B
Interest Expenses (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.03B	0.00B	0.00B	0.00B
Shares Outstanding (Quarter)	0.35B				0.38B				0.53B				1.18B			12.75B		12.90B		50.92B

Research Tools

RedHill Biopharma Income Statement (2011-2025) | RDHL

Create an account

Sign In

Reset Password